ERO HEALTH COMMUNICATIONS
Live / Registered — Registered (as of 13 Aug 2024)
What this means for you
Registered since 13 Aug 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98130310
- Registration number
- 7472484
- Mark type
- Stylized text
- Filed
- 13 Aug 2023
- Published for opposition
- 28 May 2024
- Registered
- 13 Aug 2024
Goods and services
- Class 035 — Advertising and business services: Consultancy regarding public relations communication strategies; Advertising and marketing services provided by means of indirect methods of marketing communications, namely, social media, search engine marketing, inquiry marketing, internet marketing, mobile marketing, blogging and other forms of passive, sharable or viral communications channels; Advertising services, namely, promoting and marketing the goods and services of others through all public communication means; Advertising services, public relations and marketing services, namely, promoting and marketing the goods and services of others through all public communication means; Advertising through all public communication means; Consultancy regarding advertising communication strategies
Owner
- Bersin, Erica B, New York, NY, US
- Bersin, Erica B, New York, NY, US
- Bersin, Erica B, New York, NY, US
Prosecution history
- 13 Aug 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 13 Aug 2024 — REGISTERED-PRINCIPAL REGISTER
- 28 May 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 28 May 2024 — PUBLISHED FOR OPPOSITION
- 08 May 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 23 Apr 2024 — NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
- 20 Apr 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 20 Apr 2024 — USE AMENDMENT ACCEPTED
- 18 Apr 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 18 Apr 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 18 Apr 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 18 Apr 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 18 Apr 2024 — NON-FINAL ACTION E-MAILED
- 18 Apr 2024 — NON-FINAL ACTION WRITTEN
- 12 Apr 2024 — ASSIGNED TO EXAMINER